Dr. Carson Discusses Mogamulizumab as Potential Treatment for CTCL
9 Visninger
• 08/09/23
0
0
Indlejre
administrator
Abonnenter
Kenneth R. Carson, MD, assistant professor, Division of Oncology, Washington University, discusses mogamulizumab as a potential treatment for patients with relapsed or refractory cutaneous T cell lymphoma (CTCL).
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer